| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 4.68 mm | 4.68 mm | 4.68 mm | 4.68 mm | 4.68 mm | 4.68 mm |
| Cash burn (monthly) | 3.39 mm | 1.29 mm | 2.42 mm | 2.09 mm | 2.11 mm | 1.84 mm |
| Cash used (since last report) | 17.15 mm | 6.51 mm | 12.24 mm | 10.59 mm | 10.67 mm | 9.33 mm |
| Cash remaining | -12.47 mm | -1.83 mm | -7.56 mm | -5.91 mm | -5.99 mm | -4.65 mm |
| Runway (months of cash) | -3.7 | -1.4 | -3.1 | -2.8 | -2.8 | -2.5 |
| 13F holders | Current |
|---|---|
| Total holders | 93 |
| Opened positions | 35 |
| Closed positions | 11 |
| Increased positions | 29 |
| Reduced positions | 12 |
| 13F shares | Current |
|---|---|
| Total value | 199.38 bn |
| Total shares | 42.93 mm |
| Total puts | 1.17 mm |
| Total calls | 2.75 mm |
| Total put/call ratio | 0.4 |
| Largest owners | Shares | Value |
|---|---|---|
| Orbimed Advisors | 6.94 mm | $37.15 bn |
| Samlyn Capital | 6.67 mm | $35.67 bn |
| Adams Street Partners | 3.28 mm | $17.52 bn |
| Point72 Asset Management | 3.03 mm | $16.21 bn |
| RTW Investments | 2.68 mm | $14.34 bn |
| Vanguard | 2.45 mm | $13.13 bn |
| Vivo Capital | 2.23 mm | $11.95 bn |
| Integrated Core Strategies | 1.90 mm | $0.00 |
| Richard A Miller MD | 1.77 mm | $9.34 mm |
| Foresite Capital Management VI | 1.58 mm | $8.46 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 20 Dec 24 | Jeffrey Arcara | Stock Option Common Stock | Grant | Acquire A | No | No | 4.99 | 50,000 | 249.50 k | 50,000 |
| 20 Dec 24 | Leiv Lea | Stock Option Common Stock | Grant | Acquire A | No | No | 4.99 | 300,000 | 1.50 mm | 300,000 |
| 20 Dec 24 | Richard A Miller MD | Stock Option Common Stock | Grant | Acquire A | No | No | 4.99 | 750,000 | 3.74 mm | 750,000 |
| 20 Dec 24 | William Benton Jones | Stock Option Common Stock | Grant | Acquire A | No | No | 4.99 | 300,000 | 1.50 mm | 300,000 |
| 13 Jun 24 | Gould Terry P | Stock Option Common Stock | Grant | Acquire A | No | No | 2.12 | 15,000 | 31.80 k | 15,000 |
